Does VAMOROLONE Cause Mobility decreased? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Mobility decreased have been filed in association with VAMOROLONE (AGAMREE). This represents 1.5% of all adverse event reports for VAMOROLONE.
14
Reports of Mobility decreased with VAMOROLONE
1.5%
of all VAMOROLONE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From VAMOROLONE?
Of the 14 reports, 2 (14.3%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VAMOROLONE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does VAMOROLONE Cause?
Weight increased (147)
Product dose omission issue (63)
Vomiting (49)
Asthenia (45)
Increased appetite (41)
Condition aggravated (40)
Weight decreased (38)
Headache (35)
Pyrexia (32)
Fall (31)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which VAMOROLONE Alternatives Have Lower Mobility decreased Risk?
VAMOROLONE vs VANCOMYCIN
VAMOROLONE vs VANDETANIB
VAMOROLONE vs VARDENAFIL
VAMOROLONE vs VARENICLINE
VAMOROLONE vs VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN